Vaxinano

Prophylactic and therapeutic vaccines for infectious diseases, for human and animal health markets

placeLille, Hauts De France, France calendar_todayFounded 2016 language vaxinano.com

Innovation

5 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 78 times.

YearFilings
20222
20232
20244
20251
20262

Social engagement

Social engagement: 1.9K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include TCD Capital, Nord France Amorquage, WiSEED.

Investor typeCountShare
Venture capital233%
Bank & private debt117%
Other / undisclosed350%
Coming soon